Fundraising Fox
/Companies
Sign in

GVB Biopharma

Las Vegas, US · Founded 2019 · Nevada corporation

Find your way into GVB Biopharma

Sign up to see every warm intro you have to GVB Biopharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the GVB Biopharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

GVB Biopharma is a manufacturer of cannabidiol (CBD) products, handling farming, CBD extraction, and scaled production. The company serves the legal cannabinoid and pharmaceutical ingredient market.

Advanced ManufacturingBiotechConsumerWellness & Fitness

Founders & leadership

GVB Biopharma was founded in 2019 by Drew Spiegel.

DSDrew Spiegel
Drew SpiegelCEO & Co-Founder
SRSebastian Ravitz
Sebastian RavitzChief Marketing Officer
JMJoe Maher
Joe MaherChief Financial Officer
TS
Theodore SwindellsNamed on SEC filing
PS
Phillip SwindellsCOO & Co-Founder
WS
William SpiegelNamed on SEC filing
JF
Jack FeldmanPresident & Co-Founder

Reported raises · per SEC filings

Form D private placements

$13.6M disclosed across 6 rounds · 2020–2022

▶$1MraisedMay 2022 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore SwindellsDirector
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
Minimum investment
$50K
Sales commissions
$100K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Apr 2022
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedJan 2022 · 2 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • William SpiegelExecutive Officer, Director
  • Theodore SwindellsDirector
  • Phillip SwindellsExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$1.8M
Minimum investment
$50K
Sales commissions
$25K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Jan 2022
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedNov 2021 · 10 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • William SpiegelExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
  • Theodore SwindellsDirector
  • Jack FeldmanExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$25K
Sales commissions
$100K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Oct 2021
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedNov 2020 · 28 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore SwindellsDirector
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
Offering amount
$8M
Amount sold
$7.6M
Minimum investment
$500K
Sales commissions
$640K
Placement agents
M.S. Howells & Co., TerraNova Capital Equities, Inc.
First sale
Nov 2020
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedMay 2020 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
  • Theodore SwindellsDirector
Offering amount
$3M
Amount sold
$1.3M
Minimum investment
$50K
Sales commissions
$300K
Placement agents
TerraNova Capital Equities, Inc.
First sale
May 2020
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$450KraisedApr 2020 · 4 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore SwindellsDirector
  • Phillip SwindellsExecutive Officer, Director
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
Offering amount
$2M
Amount sold
$450K
Minimum investment
$50K
Sales commissions
$200K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Feb 2020
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

LeafwellLeafwell provides personalized cannabis therapy recommendations and virtual specialty care for patients seeking treatment for various health conditions, leveraging real-world data and machine learning to optimize cannabinoid-based treatment plans.
LeaflyLeafly operates an online marketplace and information resource for cannabis, letting consumers research strains and products and order from licensed retailers, while offering customer-acquisition tools to cannabis brands and retailers. It also publishes cannabis journalism and educational resources for a worldwide consumer audience.

Companies working in the same space as GVB Biopharma.

Frequently asked questions

What does GVB Biopharma do?
GVB Biopharma is a manufacturer of cannabidiol (CBD) products, handling farming, CBD extraction, and scaled production. The company serves the legal cannabinoid and pharmaceutical ingredient market.
Who founded GVB Biopharma?
GVB Biopharma was founded by Drew Spiegel in 2019.
How much funding has GVB Biopharma raised?
GVB Biopharma has disclosed $13.6M raised across 6 rounds.
Where is GVB Biopharma headquartered?
GVB Biopharma is headquartered in Las Vegas, US.